TNB
GSK icon

Thomasville National Bank’s GSK GSK Stock Holding History

Thomasville National Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.7M Buy
+871,467
New +$46.1M 2.51% 12
2025
Q4 		$43.7M Buy
890,098
+4,260
+0.5% +$199K 2.71% 10
2025
Q3 		$38.2M Buy
885,838
+14,185
+2% +$554K 2.41% 12
2025
Q2 		$33.5M Sell
871,653
-5,344
-0.6% -$204K 2.28% 12
2025
Q1 		$34M Buy
876,997
+385,556
+78% +$14.1M 2.49% 12
2024
Q4 		$16.6M Buy
491,441
+16,057
+3% +$578K 1.19% 29
2024
Q3 		$19.4M Buy
475,384
+11,771
+3% +$482K 1.44% 23
2024
Q2 		$17.8M Buy
463,613
+9,818
+2% +$413K 1.43% 25
2024
Q1 		$19.5M Buy
453,795
+23,022
+5% +$949K 1.6% 23
2023
Q4 		$16M Buy
430,773
+8,727
+2% +$313K 1.42% 23
2023
Q3 		$15.3M Buy
422,046
+332,434
+371% +$11.8M 1.51% 22
2023
Q2 		$3.19M Buy
89,612
+8,368
+10% +$300K 0.3% 63
2023
Q1 		$2.89M Buy
81,244
+6,244
+8% +$218K 0.3% 64
2022
Q4 		$2.63M Sell
75,000
-955
-1% -$31.8K 0.3% 61
2022
Q3 		$2.23M Buy
75,955
+26,755
+54% +$1.01M 0.27% 64
2022
Q2 		$2.68M Buy
49,200
+5,148
+12% +$284K 0.3% 62
2022
Q1 		$2.4M Buy
44,052
+323
+0.7% +$17.5K 0.23% 68
2021
Q4 		$2.41M Buy
43,729
+2,593
+6% +$135K 0.23% 67
2021
Q3 		$1.97M Buy
41,136
+2,215
+6% +$111K 0.2% 72
2021
Q2 		$1.94M Buy
38,921
+5,087
+15% +$244K 0.21% 75
2021
Q1 		$1.6M Buy
33,834
+1,640
+5% +$74.4K 0.3% 55
2020
Q4 		$1.48M Buy
32,194
+1,305
+4% +$59.9K 0.19% 73
2020
Q3 		$1.45M Sell
30,889
-3,042
-9% -$152K 0.22% 71
2020
Q2 		$1.73M Buy
33,931
+661
+2% +$33.9K 0.27% 62
2020
Q1 		$1.77M Sell
33,270
-116
-0.3% -$6.19K 0.3% 65
2019
Q4 		$1.96M Buy
33,386
+116
+0.3% +$6.45K 0.3% 59
2019
Q3 		$1.77M Sell
33,270
-378
-1% -$19.4K 0.3% 65
2019
Q2 		$1.68M Buy
33,648
+1,416
+4% +$71.1K 0.29% 66
2019
Q1 		$1.68M Buy
32,232
+2,008
+7% +$100K 0.31% 61
2018
Q4 		$1.44M Sell
30,224
-1,252
-4% -$61.7K 0.3% 65
2018
Q3 		$1.58M Buy
31,476
+1,160
+4% +$58.9K 0.25% 73
2018
Q2 		$1.53M Buy
30,316
+2,133
+8% +$107K 0.26% 69
2018
Q1 		$1.38M Buy
28,183
+3,710
+15% +$173K 0.24% 72
2017
Q4 		$1.08M Sell
24,473
-12,909
-35% -$596K 0.2% 84
2017
Q3 		$1.9M Sell
37,382
-939
-2% -$47.6K 0.31% 63
2017
Q2 		$2.07M Buy
38,321
+4,358
+13% +$232K 0.38% 58
2017
Q1 		$1.79M Buy
+33,963
New +$1.72M 0.36% 59
2016
Q3 		– Sell
-25,262
Closed -$1.37M – 101
2016
Q2 		$1.37M Buy
25,262
+9,001
+55% +$474K 0.36% 61
2016
Q1 		$824K Buy
16,261
+1,091
+7% +$54.3K 0.25% 69
2015
Q4 		$765K Sell
15,170
-1,928
-11% -$98.3K 0.27% 65
2015
Q3 		$821K Buy
17,098
+156
+0.9% +$8.12K 0.3% 62
2015
Q2 		$882K Buy
16,942
+608
+4% +$34.2K 0.3% 63
2015
Q1 		$942K Sell
16,334
-231
-1% -$13.2K 0.32% 56
2014
Q4 		$885K Buy
+16,565
New +$927K 0.32% 59

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

Thomasville National Bank's GSK Position: Q2 2026 in Review

Thomasville National Bank opened a new position in GSK (GSK) in Q2 2026: 871,467 shares worth $45.7M. The stake represents 2.51% of the portfolio and ranks #12 among its holdings. This is a return to the name: Thomasville National Bank previously reported a position in GSK as recently as Q4 2025.

Thomasville National Bank first reported a position in GSK in Q4 2014 and has held it in 44 quarters since. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Thomasville National Bank held 871,467 shares of GSK worth $45.7M as of Q2 2026.
  • GSK was a new Thomasville National Bank position in Q2 2026.
  • GSK made up 2.51% of Thomasville National Bank's portfolio in Q2 2026, its #12 holding.
  • Thomasville National Bank first reported a position in GSK in Q4 2014 and has held it in 44 quarters since.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Thomasville National Bank's 13F filing for Q2 2026, filed 20 Jul 2026.